--- title: Buy Afinitor (Everolimus) 5mg/10mg Pills Online description: Afinitor (Everolimus) 5mg/10mg pills treat advanced cancers like renal cell carcinoma. Order from our secure online pharmacy for verified quality. type: product language: en url: https://liabilis.com/order-afinitor-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 314.99 price_max: 1598.99 currency: USD offers: - name: 5mg x 7 pills price: 314.99 - name: 5mg x 14 pills price: 587.99 - name: 5mg x 28 pills price: 1119.99 - name: 10mg x 7 pills price: 454.99 - name: 10mg x 14 pills price: 839.99 - name: 10mg x 28 pills price: 1598.99 --- # Buy Afinitor (Everolimus) 5mg/10mg Pills Online Afinitor, containing everolimus, is an mTOR inhibitor developed by Novartis. It treats advanced renal cell carcinoma, breast cancer, and neuroendocrine tumors. Designed for adults with progressive disease. Our online pharmacy offers a reliable way to access Afinitor in 5mg and 10mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **5mg** | 7 pills | **$314.99** | $45.00 | In Stock | | **5mg** | 14 pills | **$587.99** | $42.00 | In Stock | | **5mg** | 28 pills | **$1119.99** | $40.00 | In Stock | | **10mg** | 7 pills | **$454.99** | $65.00 | In Stock | | **10mg** | 14 pills | **$839.99** | $60.00 | In Stock | | **10mg** | 28 pills | **$1598.99** | $57.11 | In Stock | [Buy Now](https://liabilis.com/order-afinitor-online-en.html) ## Introduction Afinitor (everolimus) is an oral mTOR-inhibitor prescribed for several adult cancers and for preventing organ-rejection after kidney transplantation. It is supplied as a film-coated tablet in 5 mg and 10 mg strengths. By blocking the mammalian target of rapamycin pathway, Afinior helps to slow abnormal cell growth and to modulate the immune response. In addition to its primary oncology and transplant indications, the drug is sometimes employed in other serious conditions under specialist supervision. ## Quick Reference Facts **Active Ingredient** : everolimus **Form** : pill 5 mg | 10 mg **Primary and Off-Label Uses** : • Advanced renal cell carcinoma : • Hormone-receptor-positive, HER2-negative advanced breast cancer : • Neuroendocrine tumors of gastrointestinal or lung origin : • Subependymal giant-cell astrocytoma associated with tuberous sclerosis complex : • Prevention of rejection in kidney transplant recipients : • Off-label: certain other solid tumours, rare sarcomas, and experimental combination regimens ## What is Afinitor? Afinitor is the branded formulation of everolimus, a synthetic derivative of rapamycin. It belongs to the class of mechanistic target of rapamycin (mTOR) inhibitors. The medication was developed by Novartis and received its first regulatory approval in the United States in 2009 for advanced renal cell carcinoma. While Afinitor is the commercial name, the same active compound is available as a generic everolimus tablet, which offers comparable efficacy and safety at a lower price. Generic versions are marketed under names such as “Everolimus Tablet” and are considered bio-equivalent to the brand product. ## How Afinitor Works Everolimus binds to the intracellular protein FKBP-12, forming a complex that inhibits the mTOR complex 1 (mTORC1). mTORC1 is a key regulator of cell growth, protein synthesis, and angiogenesis. By suppressing this pathway, Afinitor reduces the proliferation of malignant cells and diminishes the production of vascular endothelial growth factor (VEGF), which tumors use to develop new blood vessels. In transplant patients, mTOR inhibition dampens T-cell activation, thereby decreasing the likelihood of organ rejection. The drug is absorbed orally, reaches peak plasma concentrations within 1-3 hours, and is primarily metabolized by CYP3A4 and CYP3A5 enzymes before renal and biliary excretion. The half-life averages 30 hours, supporting once-daily dosing. ## Conditions Treated with Afinitor - **Advanced renal cell carcinoma (RCC)** Afinitor slows tumour growth by inhibiting mTOR-driven angiogenesis, providing a survival benefit when used alone or with other agents. - **Hormone-receptor-positive, HER2-negative advanced breast cancer** When combined with an aromatase inhibitor, everolimus overcomes resistance to endocrine therapy, extending progression-free survival. - **Gastro-intestinal and lung neuroendocrine tumors (NETs)** mTOR blockade reduces hormone secretion and tumour volume, improving symptom control and disease stability. - **Subependymal giant-cell astrocytoma (SEGA) in tuberous sclerosis complex** Afinitor shrinks these brain lesions, decreasing the need for surgical intervention. - **Kidney transplantation** As part of an immunosuppressive regimen, everolimus prevents acute rejection by curbing T-cell proliferation while preserving renal function. ## Is Afinitor the Right Medication for You? Patients who have progressed on standard therapies for RCC, breast cancer, or NETs may be candidates for Afinitor, especially when molecular profiling suggests activation of the PI3K/AKT/mTOR pathway. In transplantation, individuals requiring an alternative to calcineurin inhibitors often benefit from everolimus-based protocols. Suitable candidates typically have adequate liver function (ALT/AST ≤ 3 × ULN), a creatinine clearance ≥ 30 mL/min, and no uncontrolled infections. Contraindications include known hypersensitivity to everolimus or any tablet excipient, and severe hepatic impairment (Child-Pugh C). Pregnant or breastfeeding women should avoid Afinitor because of demonstrated teratogenicity in animal studies. Patients with poorly controlled diabetes, hyperlipidaemia, or a history of non-infectious pneumonitis require close monitoring and may need dose adjustments or alternative therapy. ## Buying Afinitor from [our online pharmacy](https://liabilis.com/order-afinitor-online-en.html) ### Why Choose Our Service? Access to high-quality medications can be difficult for patients living outside major medical centres or for those facing high out-of-pocket costs. Our platform connects you with licensed suppliers that source Afinitor at near-manufacturer pricing, helping to reduce the financial burden while maintaining therapeutic continuity. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Afinitor is verified against regulatory standards and packaged under strict temperature-controlled conditions. ### Pricing & Access Because we source the generic everolimus tablet, you benefit from considerable cost savings compared with the branded product. This approach also expands availability for patients in regions where the brand may be scarce. ### Discreet Delivery Orders are shipped in unmarked packaging, with express delivery typically arriving within 7 days and standard airmail within 3 weeks. Your privacy is protected throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** • **Renal cell carcinoma or breast cancer:** 10 mg orally once daily, taken on an empty stomach (≥ 1 hour before or after food). • **Neuroendocrine tumors:** 10 mg once daily; dose may be reduced to 5 mg if intolerance occurs. • **Kidney transplant:** 0.75 mg/kg (maximum 5 mg) once daily, often given in the morning with food to minimise gastrointestinal upset. - **Missed dose** If you remember the dose within 12 hours, take it immediately. If more than 12 hours have passed, skip the missed dose and resume the regular schedule. Do not double-dose. - **Overdose** Symptoms may include severe nausea, vomiting, diarrhoea, dizziness, or respiratory depression. Seek emergency medical care promptly. Provide the product name, strength, and amount taken. - **Practical precautions** • Avoid grapefruit or grapefruit juice, as they can increase everolimus blood levels. • Do not consume alcohol in excess; it may exacerbate hepatic side effects. • Refrain from operating heavy machinery until you know how the medication affects you, especially during the first weeks of therapy. ## Safety Information ### ⚠️ Who Should Not Take Afinitor - Known hypersensitivity to everolimus or any tablet ingredient. - Severe hepatic impairment (Child-Pugh C). - Pregnant individuals; the drug is contraindicated because of fetal risk. ### Common Side Effects - **Stomatitis (mouth sores):** occurs in up to 50 % of patients; manage with good oral hygiene and topical steroid rinses. - **Diarrhoea:** mild to moderate; stay hydrated and consider antidiarrheal agents if needed. - **Rash or acne-like eruptions:** treat with moisturisers or low-potency corticosteroids. - **Fatigue:** usually transient; assess sleep hygiene and activity levels. ### Serious Side Effects (Seek Immediate Medical Help) - **Non-infectious pneumonitis:** new or worsening cough, shortness of breath, or fever. - **Severe infections:** signs include high fever, chills, or unexplained pain. - **Hyperglycaemia:** persistent thirst, polyuria, or unexplained weight loss. - **Renal failure:** reduced urine output, swelling, or sudden weight gain. ### Drug & Food Interactions - **CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin):** increase everolimus exposure; dose reduction may be required. - **CYP3A4 inducers (e.g., rifampin, carbamazepine):** lower drug levels; may reduce efficacy. - **Antacids containing aluminium or magnesium:** can affect absorption; separate administration by at least 2 hours. - **Warfarin:** monitor INR more frequently, as everolimus may potentiate anticoagulant effect. ## Off-Label and Investigational Uses of Afinitor Clinical studies have explored everolimus in malignant melanoma, pancreatic cancer, and certain sarcomas, showing variable activity. Some oncologists use the drug in combination with checkpoint inhibitors for advanced solid tumours, citing synergistic immunomodulation. These applications remain investigational; efficacy and safety have not received formal regulatory approval. Patients considering off-label use should do so only under the direct supervision of a qualified oncology specialist. ## Storage & Handling - **Temperature:** Store tablets at 20-25 °C (68-77 °F); excursions between 15 °C and 30 °C are acceptable. - **Moisture:** Keep container tightly closed to protect from humidity. - **Light:** Store in the original blister pack away from direct sunlight. - **Expiry:** Do not use beyond the printed expiration date; discard any tablets that appear discoloured or damaged. - **Disposal:** Return unused medication to a pharmacy-based take-back program or follow local hazardous-waste guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Afinitor?** Yes, but keep the medication in its original labelled container, carry a copy of the prescription, and be aware of the importing regulations of your destination country. - **Should I take Afinitor with meals?** For most oncology indications it is best taken on an empty stomach; for transplant protocols the drug is often taken with food to lessen gastrointestinal irritation. - **Will alcohol affect my treatment?** Moderate alcohol use is not prohibited, but excessive consumption can worsen liver toxicity and increase the risk of infections. **Product & Formulation Details** - **What do Afinitor tablets look like?** The 5 mg tablets are white, round, and film-coated; the 10 mg tablets are pink, oval, and also film-coated. - **Can the tablet be split?** Neither strength is scored, so splitting is not recommended because it may result in dose inaccuracy. **Regulatory & Safety Nuances** - **Is Afinitor detectable on standard drug tests?** Everolimus is not typically screened for in workplace or athletic drug-testing panels. - **Can athletes use Afinitor?** The drug is not listed on the World Anti-Doping Agency prohibited list, but athletes should verify with their governing body, especially if combined with other prohibited substances. - **Is Afinitor safe for elderly patients?** Older adults may experience higher rates of infections and pneumonitis; dose adjustments and close monitoring are advised. **Scientific & Clinical Curiosity** - **What was the key trial that led to Afinitor’s approval for RCC?** The RECORD-1 study demonstrated a median progression-free survival benefit of 4.6 months versus placebo in patients with advanced RCC after failure of prior VEGF-targeted therapy. - **How does everolimus differ from rapamycin (sirolimus)?** Everolimus has a shorter side-chain, resulting in improved oral bioavailability and a more predictable pharmacokinetic profile compared with sirolimus. ## Glossary **mTOR (mechanistic target of rapamycin)** : A cellular kinase that regulates growth, metabolism, and angiogenesis; inhibition slows tumour proliferation. **CYP3A4** : A liver enzyme that metabolises many drugs; inhibitors raise, and inducers lower, everolimus concentrations. **Non-infectious pneumonitis** : Inflammation of lung tissue not caused by infection; a recognized immune-mediated adverse effect of mTOR inhibitors. **Bioequivalence** : Demonstrated similarity in rate and extent of absorption between a generic drug and its branded counterpart. ## Disclaimer The information provided about **Afinitor** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-afinitor-online-en.html) offers access to **Afinitor** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.